Shen Yi-Chun, Lin You-Zhe, Wu Wan-Rong, Lin Pei-Le, Liao Chien-Ching, Chung Feng-Chi, Chen Chia-Yun, Weng Ching-Yu, Wang Shao-Chun
Center for Molecular Medicine, China Medical University Hospital, Taichung 404327, Taiwan.
Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung 406040, Taiwan.
Biomedicine (Taipei). 2024 Sep 1;14(3):40-48. doi: 10.37796/2211-8039.1462. eCollection 2024.
The intricately orchestrated progression of mammary tissue development involves the precise coordination of gland differentiation and cellular proliferation. Nevertheless, the understanding of the role and regulatory mechanisms governing the DNA replication machinery in mammary gland development remains limited. Given the essential role of DNA replication in the viability of living cells, any genetic disturbance to its replicative function, in any form, will impede organ development. This circumstance poses a technical challenge in elucidating the potential function of cell proliferation in mammary morphogenesis. PCNA is crucial in DNA replication, playing a pivotal role in the development of complete eukaryotic organisms. The phosphorylation of PCNA at tyrosine 211 (Y211) has been demonstrated to play a significant role in supporting replication forks and, consequently, cell proliferation. Therefore, the utilization of a knock-in mouse model, wherein the Y211 residue of PCNA is replaced with phenylalanine (211F), presents an opportunity to evaluate the impact of reduced cell proliferation potential on mammary gland development. Interestingly, the lack of Y211 phosphorylation did not significantly impact the rates of proliferation or cell death in the mammary gland. In contrast, the absence of Y211PCNA led to an increased, rather than reduced, growth of the mammary gland. This was evident in assessments of gland length and the number of terminal end buds (TEBs) in both postnatal and virgin mammary glands. Notably, this observation correlated with an elevation in tissue stemness within the 211F glands compared to the WT glands. Additionally, it was consistent with the greater body weight gains observed in 211F pups compared to WT pups during the weaning period. Our findings unveil an unexpected aspect that may carry significance for mammary development. This newfound is associated with the regulation of a central component within the DNA replication machinery, providing insights into the intricate interplay governing mammary tissue expansion.
乳腺组织发育这一精心编排的过程涉及腺体分化和细胞增殖的精确协调。然而,对于DNA复制机制在乳腺发育中的作用及调控机制的理解仍然有限。鉴于DNA复制在活细胞生存能力中的关键作用,其复制功能的任何形式的遗传干扰都会阻碍器官发育。这种情况在阐明细胞增殖在乳腺形态发生中的潜在功能方面构成了技术挑战。增殖细胞核抗原(PCNA)在DNA复制中至关重要,在完整真核生物的发育中起关键作用。已证明PCNA酪氨酸211(Y211)位点的磷酸化在支持复制叉从而促进细胞增殖方面发挥重要作用。因此,利用一种敲入小鼠模型,其中PCNA的Y211残基被苯丙氨酸取代(211F),为评估细胞增殖潜能降低对乳腺发育的影响提供了一个机会。有趣的是,Y211磷酸化的缺失并未显著影响乳腺中的增殖率或细胞死亡率。相反,缺乏Y211PCNA导致乳腺生长增加而非减少。这在产后和处女乳腺的腺体长度和末端终芽(TEB)数量的评估中很明显。值得注意的是,这一观察结果与211F腺体中组织干性相对于野生型(WT)腺体的升高相关。此外,这与断奶期211F幼崽相对于WT幼崽观察到的更大体重增加一致。我们的研究结果揭示了一个可能对乳腺发育具有重要意义的意外方面。这一新发现与DNA复制机制中一个核心成分的调控有关,为乳腺组织扩张的复杂相互作用提供了见解。